Literature DB >> 7888078

Comparison of properties of membrane bound versus soluble forms of human leukocytic elastase and cathepsin G.

N Bangalore1, J Travis.   

Abstract

Stimulation of human neutrophils with micromolar concentrations of N-formyl-methionyl-leucyl-phenyl-alanine (fMLP) or 4 beta-phorbol-12 beta-myristate-13 alpha-acetate (PMA), results in their degranulation and/or lysis with a concomitant release of Human Leucocyte Elastase (HLE; EC 3.4.21.37), Cathepsin G (cat G; EC 3.4.21.20) and Myeloperoxidase (MPO; EC 1.11.1.7) into the surrounding medium, some of which re-bind in an active form to neutrophil plasma membranes or membrane fragments. Histones, when present in the medium, prevent this association indicating that it is largely charge dependent. Bound proteinases have an increased resistance to inhibition by protein proteinase inhibitors, while bound MPO retains its ability to oxidatively inactivate alpha-1-proteinase inhibitor (alpha-1-PI). The attachment of oxidases and proteinases to plasma membrane or its fragments may allow them to remain active in an environment replete with proteinase inhibitors and, therefore, may be responsible for neutrophil or neutrophil-debris mediated tissue damage.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7888078     DOI: 10.1515/bchm3.1994.375.10.659

Source DB:  PubMed          Journal:  Biol Chem Hoppe Seyler        ISSN: 0177-3593


  12 in total

1.  The 1.8 A crystal structure of human cathepsin G in complex with Suc-Val-Pro-PheP-(OPh)2: a Janus-faced proteinase with two opposite specificities.

Authors:  P Hof; I Mayr; R Huber; E Korzus; J Potempa; J Travis; J C Powers; W Bode
Journal:  EMBO J       Date:  1996-10-15       Impact factor: 11.598

2.  Self antigen prognostic for human immunodeficiency virus disease progression.

Authors:  C L Bristow; H Patel; R R Arnold
Journal:  Clin Diagn Lab Immunol       Date:  2001-09

3.  Heparin accelerates the inhibition of cathepsin G by mucus proteinase inhibitor: potent effect of O-butyrylated heparin.

Authors:  J Ermolieff; J Duranton; M Petitou; J G Bieth
Journal:  Biochem J       Date:  1998-03-15       Impact factor: 3.857

4.  Fibrinogen is degraded and internalized during incubation with neutrophils, and fibrinogen products localize to electron lucent vesicles.

Authors:  Richard Kirsch; Mohamed A Jaffer; Vivienne E Woodburne; Trevor Sewell; Sharon L Kelly; Ralph E Kirsch; Enid G Shephard
Journal:  Biochem J       Date:  2002-06-01       Impact factor: 3.857

5.  Measurement of free and membrane-bound cathepsin G in human neutrophils using new sensitive fluorogenic substrates.

Authors:  Sylvie Attucci; Brice Korkmaz; Luiz Juliano; Eric Hazouard; Catherine Girardin; Michèle Brillard-Bourdet; Sophie Réhault; Philippe Anthonioz; Francis Gauthier
Journal:  Biochem J       Date:  2002-09-15       Impact factor: 3.857

Review 6.  Leukocyte cell surface proteinases: regulation of expression, functions, and mechanisms of surface localization.

Authors:  Caroline A Owen
Journal:  Int J Biochem Cell Biol       Date:  2008-01-31       Impact factor: 5.085

7.  Eryptotic phenotype in chronic myeloid leukemia: contribution of neutrophilic cathepsin g.

Authors:  Rukmini Govekar; Poonam Kawle; Renjan Thomas; Suresh Advani; Sheena Pv; Surekha Zingde
Journal:  Anemia       Date:  2012-03-14

8.  Relative α₁-anti-trypsin deficiency in systemic sclerosis.

Authors:  Theresa C Barnes; Andy Cross; Marina E Anderson; Steven W Edwards; Robert J Moots
Journal:  Rheumatology (Oxford)       Date:  2011-03-30       Impact factor: 7.580

9.  Tamm-Horsfall glycoprotein enhances PMN phagocytosis by binding to cell surface-expressed lactoferrin and cathepsin G that activates MAP kinase pathway.

Authors:  Syue-Cian Siao; Ko-Jen Li; Song-Chou Hsieh; Cheng-Han Wu; Ming-Chi Lu; Chang-Youh Tsai; Chia-Li Yu
Journal:  Molecules       Date:  2011-03-03       Impact factor: 4.411

10.  Alphataxin, an Orally Available Small Molecule, Decreases LDL Levels in Mice as a Surrogate for the LDL-Lowering Activity of Alpha-1 Antitrypsin in Humans.

Authors:  Cynthia L Bristow; Ronald Winston
Journal:  Front Pharmacol       Date:  2021-06-09       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.